Share on LinkedInShare on LinkedIn

ARTICLE · 10 JANUARY 2022

France Addresses COVID-19 With Additional Measures

Mayer Brown
Mayer Brown
Contributor
Mayer Brown

Mayer Brown

Mayer Brown is a leading international law firm positioned to represent the world’s major...

View firm profile
Explore more from Mayer Brown

France entered the new year not in the most festive of moods. On December 31, 2021, the country had reached a sad record—262,000 new COVID-19 infections in only 24 hours.

FranceCoronavirus (COVID-19)

France entered the new year not in the most festive of moods. On December 31, 2021, the country had reached a sad record—262,000 new COVID-19 infections in only 24 hours. To face this unprecedented situation and the extremely fast-spreading new variant, the government has implemented new measures to address the pandemic while a bill to reinforce existing tools for managing the health crisis is being debated in Parliament.

Working from home

The French Labor Minister has published a new COVID-19 Health and Safety Protocol for companies.

As of January 3, 2022, and for 3 weeks, eligible employees (i.e. employees who can perform their work remotely) should work from home at least 3 days (or 4 days, if possible) per week.

In addition, the bill in Parliament could prescribe:

  • That homeworking for 3 (or 4) days a week would be mandatory. As a reminder, to date, the government's COVID-19 Health and Safety Protocol ("Health Protocol") has no binding value;
  • An administrative fine if an employer fails to comply with its general health and safety obligation when a dangerous situation results from a risk of exposure to COVID-19. The fine could go up to €1000 per employee concerned, capped at €50,000 per company. In practice, this could allow the labor inspector to sanction any employer that does not comply with the recommendations of the Health Protocol regarding homeworking.

Isolation duration

The Direction Générale de la Santé has published new guidelines on isolation, which are summarized in the table below:

 

Individual infected with COVID-19

Contact with an individual infected with COVID-19

Fully vaccinated individual
  • 7-days quarantine
  • Possible release from quarantine after 5 days with a negative PCR or antigen test

An exception is made for the medical and health sector

  • No quarantine
  • Social distancing
  • Need to undergo:
    • a PCR or antigen test immediately and conducted by a healthcare provider.
    • a self-test 2 days after the last contact
    • a self-test 4 days after the last contact.
 Not fully vaccinated or not vaccinated at all
  •  10-days quarantine
  • Possible release from quarantine after 7 days with a negative PCR or antigen test
  •  7-days quarantine 
  • Possible release from quarantine with a negative PCR or antigen test

Still, these guidelines are aimed at employees only, since the employer cannot request their employees to share their vaccination status (except in certain sectors, as specified below).

Implementation of a "vaccine pass"

According to the bill in Parliament, the "vaccine pass" would replace the "health pass" (passe sanitaire) The bill is still debated, but the government's objective is for the vaccine pass to be effective as of January 15, 2022. As a result, it would no longer be possible for employees in establishments open to the public (ERP) to return to work in these establishments by presenting a negative PCR or antigen test or a certificate of recovery from COVID-19; instead, these employees would be required to show proof of vaccination. Still, the bill would not make vaccination mandatory for employees of most companies— those that do not operate in specific sectors open to the public, for example, those outside the hospitality and health sectors.

Occupational health

The bill could allow the occupational doctor to access to the list of unvaccinated employees in order to engage in a dialogue with them. This information should not be shared with the employer.

Visit us at mayerbrown.com

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2021. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.

Visit us at mayerbrown.com

Mayer Brown is a global services provider comprising associated legal practices that are separate entities, including Mayer Brown LLP (Illinois, USA), Mayer Brown International LLP (England & Wales), Mayer Brown (a Hong Kong partnership) and Tauil & Chequer Advogados (a Brazilian law partnership) and non-legal service providers, which provide consultancy services (collectively, the “Mayer Brown Practices”). The Mayer Brown Practices are established in various jurisdictions and may be a legal person or a partnership. PK Wong & Nair LLC (“PKWN”) is the constituent Singapore law practice of our licensed joint law venture in Singapore, Mayer Brown PK Wong & Nair Pte. Ltd. Details of the individual Mayer Brown Practices and PKWN can be found in the Legal Notices section of our website. “Mayer Brown” and the Mayer Brown logo are the trademarks of Mayer Brown.

© Copyright 2024. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.

See more popular content from